Ciao Daniela, ho molto apprezzato il fatto che sposti il problema su un piano 
epistemologico e condivido che per la clinica il paradigma indiziario sia più 
indicato dei big data. Sono entrambe scelte rare e preziose. (Junio • Pisa)

> Il giorno 10 feb 2026, alle ore 12:00, [email protected] ha 
> scritto:
> 
> Send nexa mailing list submissions to
> [email protected]
> 
> To subscribe or unsubscribe via the World Wide Web, visit
> https://server-nexa.polito.it/mailman/listinfo/nexa
> or, via email, send a message with subject or body 'help' to
> [email protected]
> 
> You can reach the person managing the list at
> [email protected]
> 
> When replying, please edit your Subject line so it is more specific
> than "Re: Contents of nexa digest..."
> 
> 
> Today's Topics:
> 
>  1. Nuovo articolo, The imaginary patient. Fantastic health data
>     and where to find them (Daniela Tafani)
> 
> 
> ----------------------------------------------------------------------
> 
> Message: 1
> Date: Mon, 9 Feb 2026 14:01:41 +0000
> From: Daniela Tafani <[email protected]>
> To: nexa <[email protected]>
> Subject: [nexa] Nuovo articolo, The imaginary patient. Fantastic
> health data and where to find them
> Message-ID:
> <pawpr07mb955898e81e7f5a2b86bfad35f3...@pawpr07mb9558.eurprd07.prod.outlook.com>
> 
> Content-Type: text/plain; charset="Windows-1252"
> 
> Buongiorno,
> 
> ho appena pubblicato un articolo sui chatbot e la medicina
> e vi sarei molto grata di qualsiasi osservazione.
> 
> The imaginary patient. Fantastic health data and where to find them
> <https://btfp.sp.unipi.it/en/2026/01/the-imaginary-patient/>
> 
> Abstract
> In the name of an upcoming AI revolution in healthcare and of chatbots and 
> ‘agentic AI’ allegedly capable of providing health advice, the US, 
> international institutions, and the European Commission are pushing for the 
> digitisation of clinical and health data.
> Unfortunately, ‘digitisation’ is just a new name for mass surveillance, there 
> is no such a thing as  ‘agentic AI’ and those surveilling us are not 
> interested in making healthcare more accessible or personalised, which would 
> simply require hiring more healthcare personnel.
> At best, a machine learning system capable of tracking correlations can be an 
> auxiliary tool in medicine. An extruder of probable text strings can only 
> make us imagine that we are in a doctor–patient relationship, but what a 
> doctor does is certainly not autocomplete. A chatbot is therefore both 
> useless and dangerous, if the objective is healthcare. However, a private 
> healthcare company whose goal is to increase quarterly dividends may consider 
> a chatbot to be a useful cost-reduction tool. Within an instrumental 
> rationality, a healthcare company may find it rational to replace doctors 
> with chatbots, just as it would find it rational to feed prisoners dog food 
> if it ran a prison. After all, financial analysts who think in terms of 
> business logic are seriously asking themselves whether treating patients is a 
> sustainable business model.
> Announcements of an AI-based healthcare revolution have no scientific basis. 
> However, they are deeply rooted in sectors that are heavily funded by the 
> pharmaceutical industry and technology companies. Here, the interest in 
> promises of automation, in dehumanising patients, in commodifying health and 
> in destroying public healthcare systems converge with the surveillance, 
> control, manipulation and domination goals of the US military–industrial 
> complex.
> Even if it cannot cure us, generative AI is perfect for all these purposes.
> 
> Un saluto,
> Daniela
> 
> ------------------------------
> 
> Subject: Digest Footer
> 
> _______________________________________________
> nexa mailing list
> [email protected]
> https://server-nexa.polito.it/mailman/listinfo/nexa
> 
> 
> ------------------------------
> 
> End of nexa Digest, Vol 202, Issue 9
> ************************************

Reply via email to